BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2594 related articles for article (PubMed ID: 18669134)

  • 1. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
    Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
    J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
    Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
    Eberlein B; Eicke C; Reinhardt HW; Ring J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N; Erdem C
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate for the treatment of adult atopic dermatitis.
    Goujon C; Bérard F; Dahel K; Guillot I; Hennino A; Nosbaum A; Saad N; Nicolas JF
    Eur J Dermatol; 2006; 16(2):155-8. PubMed ID: 16581567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children.
    Roberts H; Orchard D
    Australas J Dermatol; 2010 May; 51(2):128-30. PubMed ID: 20546220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
    Wolff K; Fleming C; Hanifin J; Papp K; Reitamo S; Rustin M; Shear N; Silny W; Korman N; Marks I; Cherill R; Emady-Azar S; Paul C;
    Br J Dermatol; 2005 Jun; 152(6):1296-303. PubMed ID: 15948996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 130.